Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, pursuant to the Answer of 2 February 2015 to Question 221865, what assessment his Department has made of the effect on future cancer patient outcomes of using alternative cancer drugs fund drugs and conventional treatments instead of any of the treatments due to be delisted.

The Department has not made any such assessment. NHS England considers that the changes it is making to the drugs available on the Cancer Drugs Fund national list will deliver the greatest benefit to cancer patients and ensure that more patients will be able to access the latest drugs that provide better outcomes for their cancers.